Vaxxas announced that it began a multi-center Phase I clinical trial of a vaccine against avian flu using its high-density ...

Research results show that protein embeddings are reliable, highly-accurate predictors of nanobody melting temperatures.

Vaxxas has commenced a Phase I clinical trial for a pre-pandemic avian influenza A virus (H7N9) vaccine, leveraging a high-density microarray patch (HD-MAP) for delivery. Vaxxas' HD-MAP platform, ...

Vaxxas today announced that it has initiated a multi-center Phase I clinical trial of a vaccine against pre-pandemic avian ...

But to realize these potential benefits, researchers first need to overcome challenges and decrease toxicity, increase their ability to escape from the endosomes, increase their thermostability ...

Doherty Clinical Trials is calling for healthy volunteers to participate in a phase one trial of the vaccines to assess the ...

Diterpene glycosyltransferase UGT76G1 is a key enzyme in the biosynthesis of rebaudioside A, a naturally sweet-tasting compound, however, its poor thermostability hinders its industrial application.

Vaxxas has initiated a multi-centre Phase 1 clinical trial of a vaccine against pre-pandemic avian influenza strain H7N9, using its high-density ...